CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD ris...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/122 |
| _version_ | 1797882530503852032 |
|---|---|
| author | E. V. Privalova V. Yu. Kaplunova N. V. Khabarova G. A. Shakaryants Yu. N. Belenkov |
| author_facet | E. V. Privalova V. Yu. Kaplunova N. V. Khabarova G. A. Shakaryants Yu. N. Belenkov |
| author_sort | E. V. Privalova |
| collection | DOAJ |
| description | One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD risk. The available clinical evidence suggests that SCD risk stratification is an effective algorithm for determining the need for preventive treatment. The latter should be individualised, based on the risk levels in each patient. |
| first_indexed | 2024-04-10T03:37:16Z |
| format | Article |
| id | doaj.art-5d3f4a7ea6bf4cd5bc5db4ffa454fa02 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:37:16Z |
| publishDate | 2013-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-5d3f4a7ea6bf4cd5bc5db4ffa454fa022023-03-13T07:23:22Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-02-01121737910.15829/1728-8800-2013-1-73-79122CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)E. V. Privalova0V. Yu. Kaplunova1N. V. Khabarova2G. A. Shakaryants3Yu. N. Belenkov4ГБОУ ВПО Первый московский государственный медицинский университет имени И.М. СеченоваНаучно-исследовательский отдел НОК центр “Метаболический синдром” НИЦ Минздрава России, МоскваНаучно-исследовательский отдел НОК центр “Метаболический синдром” НИЦ Минздрава России, МоскваГБОУ ВПО Первый московский государственный медицинский университет имени И.М. СеченоваГБОУ ВПО Первый московский государственный медицинский университет имени И.М. СеченоваOne of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD risk. The available clinical evidence suggests that SCD risk stratification is an effective algorithm for determining the need for preventive treatment. The latter should be individualised, based on the risk levels in each patient.https://cardiovascular.elpub.ru/jour/article/view/122гипертрофическая кардиомиопатиястратификация риска внезапной сердечной смертипрофилактика внезапной сердечной смертикардиовертер-дефибриллятор |
| spellingShingle | E. V. Privalova V. Yu. Kaplunova N. V. Khabarova G. A. Shakaryants Yu. N. Belenkov CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) Кардиоваскулярная терапия и профилактика гипертрофическая кардиомиопатия стратификация риска внезапной сердечной смерти профилактика внезапной сердечной смерти кардиовертер-дефибриллятор |
| title | CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) |
| title_full | CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) |
| title_fullStr | CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) |
| title_full_unstemmed | CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) |
| title_short | CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) |
| title_sort | current recommendations on risk stratification and sudden cardiac death prevention in patients with hypertrophic cardiomyopathy based on the 2011 recommendations by the american college of cardiology american heart association |
| topic | гипертрофическая кардиомиопатия стратификация риска внезапной сердечной смерти профилактика внезапной сердечной смерти кардиовертер-дефибриллятор |
| url | https://cardiovascular.elpub.ru/jour/article/view/122 |
| work_keys_str_mv | AT evprivalova currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation AT vyukaplunova currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation AT nvkhabarova currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation AT gashakaryants currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation AT yunbelenkov currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation |